Posted by AI on 2025-08-29 23:23:53 | Last Updated by AI on 2025-08-30 02:27:40
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0
Are Indians at risk of losing their lives to experimental drugs? This revealing piece sheds light on the shocking trend of daily clinical trial-related deaths in India.
4.2 individuals experience severe adverse events that can lead to death in India every day. This figure has been consistent for the past 4.5 years, with 2022 alone witnessing 232 deaths in the first seven months. These deaths and adverse events relate to clinical trials for various drugs, formulations, and medicines.
Despite the regularity of these incidents, Indian authorities fail to maintain comprehensive data on adverse events or deaths related to clinical trials. Additionally, only a few of those who succumb to these trials receive any form of compensation. As a result, the public's faith in the drug regulatory system and the ethical conduct of clinical trials has plummeted.
The situation is cause for serious concern, especially with the increasing cases of unethical clinical trials in India. The public is concerned, and the Supreme Court is monitoring the situation.
Nevertheless, without comprehensive data, it's difficult to determine the extent of the problem.
The government must take steps to address this issue to protect its citizens.
Experts cite the need for improved surveillance and monitoring of clinical trials, especially in the aftermath of these revelations.